New shot tested to tame severe childhood eczema
NCT ID NCT06324812
Summary
This study is testing a new injectable drug called 611 in Chinese children and teenagers with moderate to severe atopic dermatitis (eczema). The main goals are to check if the drug is safe, how it moves through the body, and if it can reduce the severity of skin symptoms and itching. The drug works by targeting a specific protein involved in the inflammation that causes eczema.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100003, China
Conditions
Explore the condition pages connected to this study.